Estradiol Patch
Product Images NDC 0378-4621

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Estradiol (NDC 0378-4621). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Export 00

Export 00
FDA Label Image

Export 01

Export 01
FDA Label Image

Export 02

Export 02
FDA Label Image

Export 03

Export 03
FDA Label Image

Export 04

Export 04
FDA Label Image

Export 05

Export 05
FDA Label Image

Export 06

Export 06
FDA Label Image

Export 07

Export 07
FDA Label Image

Export 08

Export 08
FDA Label Image

Export 09

Export 09
The text indicates a serum concentration in pg/mL and dosage in mg per day. There is also a time measurement in days. However, without more context or information, the purpose or significance of these measurements cannot be determined.*
FDA Label Image

Export 10

Export 10
This appears to be a list of three items related to some kind of product packaging or medical device. (1) "Backing" may refer to a material used on the back or underside of something, such as a tape or bandage, to provide support or cushioning. (2) "Adhesive containing estradiol" suggests that there is an adhesive substance present that also contains or delivers the hormone estradiol, which is commonly used in hormone replacement therapy for menopause. This could potentially indicate a medical or topical treatment delivery system. (3) "Oversized protective liner" could refer to a larger-than-usual layer of protection or padding that is included in the packaging of an item to prevent damage during handling or transport. Overall, it is difficult to determine the exact nature or purpose of these items without additional context.*
FDA Label Image

Export 11

Export 11
FDA Label Image

Estradiol Transdermal System (twice-weekly) 0.025 mg/day Carton Label (Image 13)

Estradiol Transdermal System (twice-weekly) 0.025 mg/day Carton Label (Image 13)
This is a description of a Transdermal System that includes eight systems. Each 2.5t system contains estradiol, USP hemihydrate, quickly 10041 mg of estradiol, and delivers 0.025 mg/day. The product is to be stored at controlled room temperature between 20° to 25°C. The Dosage and Administration details are available in the package near the Mylan® logo. The other information has unclear context and cannot be determined.*
FDA Label Image

Estradiol Transdermal System (twice-weekly) 0.0375 mg/day Carton Label (Image 14)

Estradiol Transdermal System (twice-weekly) 0.0375 mg/day Carton Label (Image 14)
FDA Label Image

Estradiol Transdermal System (twice-weekly) 0.05 mg/day Carton Label (Image 15)

Estradiol Transdermal System (twice-weekly) 0.05 mg/day Carton Label (Image 15)
This is a description of a transdermal system that delivers 0.05 mg per day and includes 8 systems. The package insert includes information about dosage and administration, as well as storage instructions. The text contains some gibberish and non-English characters, but is still somewhat readable.*
FDA Label Image

Estradiol Transdermal System (twice-weekly) 0.075 mg/day Carton Label (Image 16)

Estradiol Transdermal System (twice-weekly) 0.075 mg/day Carton Label (Image 16)
FDA Label Image

Estradiol Transdermal System (twice-weekly) 0.1 mg/day Carton Label (Image 17)

Estradiol Transdermal System (twice-weekly) 0.1 mg/day Carton Label (Image 17)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.